Cardiff Oncology, Inc. (CRDF) has 4 SEC Form 4 insider filings on record in the last 90 days. That includes 4 insider purchases totalling $1.1M. Most recent filing: July 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 16, 2026 filed July 14, 2026 | PACE GARY W Director | +$1,000,000 | 1,374,570 | New | No | |
|
|
||||||
| July 16, 2026 filed July 14, 2026 | Mohindru Mani Chief Executive Officer | +$50,000 | 68,728 | New | No | |
|
|
||||||
| June 22, 2026 filed June 18, 2026 | PACE GARY W Director | +$36,600 | 30,000 | +2% | No | |
|
|
||||||
| June 22, 2026 filed June 18, 2026 | Mohindru Mani Chief Executive Officer | +$29,891 | 24,703 | New | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free